Skip to main content

Table 3 Saturation grid

From: Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REAL™): a patient-reported outcome measure for lupus disease activity

SYMPTOM SATURATION
s = spontaneous
p = probed
u = don t know
  Participants
Male (M)/ Female (F) F F M F F F F F F M
Race / Ethnicity Hispanic/Latino Black/Afr ican Am White Black/Afr ican Am Hispanic/Latino White Am Indian/AIaskan Nat Black/Afr ican Am Asian/Other Hispanic/Latino
Interview Date 18-Mar 23-Mar 23-Mar 24-Mar 24-Mar 25-Mar 29-Mar 29-Mar 4-Apr 5-Apr
IDs (N = 8) 201–001 201–004 201–006 101–001 201–005 201–003 101–003 101–002 201–008 201–007
n % n % n %           
  OVERALL SPONTANEOUS PROBED           
Joint/bone pain, stiffness or swelling (arthritis, arthritislike symptoms) 10 100% 10 100% 0 0% S s s s s s s s s s
Fatigue 10 100% 5 50% 5 50% S s P P P P s s s P
Swelling 9 90% 6 60% 3 30% P p s s s s p s s  
Weakness 9 90% 2 20% 7 70% P p s p p p p   s P
Difficulty breathing/shortness of breath 8 80% 5 50% 3 30% P   s p s s s   p S
Skin problems (e.g., rash, pigmentation) 8 80% 5 50% 3 30% s   u s s s p s p P
Chest pain 7 70% 2 20% 5 50% p    p p s u s p P
Tiredness 6 60% 4 40% 2 20% s   p   s s   u p s
Hair loss 6 60% 2 20% 4 40% p p p s    u s p u
Muscle pain, aching or stiffness 5 50% 2 20% 3 30% p    p s p s u   
Fever 5 50% 2 20% 3 30% s s   p   p     p
Other* 7 70% 7 70% 0 0% s s s s s s s   s s